Adalimumab (humira™) in ophthalmology: a review of the literature.

about

A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease Childhood Visual Impairment and other Challenges in the Middle East and African Region.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.

P2860

Q26777598-212C6F1F-2BCF-494E-ADB0-B49B6D23422F Q34348454-CA30CF1A-063A-42EA-94BE-9730F2BB5211 Q47729137-6F501E0C-C651-4437-B726-1ABC7AC7A06A

P2860

Adalimumab (humira™) in ophthalmology: a review of the literature.

Item

http://www.wikidata.org/entity/Q37823308

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adalimumab (humira™) in ophthalmology: a review of the literature.

@en

type

Item

label

Adalimumab (humira™) in ophthalmology: a review of the literature.

@en

prefLabel

Adalimumab (humira™) in ophthalmology: a review of the literature.

@en

P1476

Adalimumab (humira™) in ophthalmology: a review of the literature.

@en

P2093

Alfonso Giovannini

http://www.w3.org/2001/XMLSchema#string

Cinzia Fortuna

http://www.w3.org/2001/XMLSchema#string

Manuela Zucchi

http://www.w3.org/2001/XMLSchema#string

Mara Manoni

http://www.w3.org/2001/XMLSchema#string

Marta Lettieri

http://www.w3.org/2001/XMLSchema#string

Silvia Celani

http://www.w3.org/2001/XMLSchema#string

P2860

TNF-R1 signaling: a beautiful pathway

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Role of cytokines in rheumatoid arthritis

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study

Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint disease.

Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis.

P304

290-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.4103/0974-9233.71588

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Piergiorgio Neri

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21180427

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab

P932

2991444

http://www.w3.org/2001/XMLSchema#string

Adalimumab (humira™) in ophthalmology: a review of the literature.

about

P2860

P2860

Adalimumab (humira™) in ophthalmology: a review of the literature.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932